NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » pressreleases » Accelerated healing with NATROX® O₂: Managing Late Radiation Tissue Injury Post-Mohs Surgery

NATROX® Wound Care

Press
Release

Accelerated healing with NATROX® O₂: Managing Late Radiation Tissue Injury Post-Mohs Surgery

NATROX® Wound Care, a leading innovator in wound management solutions, is pleased to announce the publication of a groundbreaking study in WOUNDS journal, highlighting the potential of NATROX® O₂ in managing late radiation tissue injury following Mohs surgery.

Conducted by esteemed researchers Lawrence R. LoDico III, CWS, ATP, COF, Dr. Windy Cole, DPM, CWSP, and Emma Woodmansey, PhD, the case series delves into the efficacy of NATROX® O₂, a continuous topical oxygen therapy (cTOT), in supporting wound healing, particularly in advanced-age patients post-Mohs surgery.

Mohs surgery, while effective in treating skin cancer, often leads to chronic radiation wounds and late radiation tissue injuries, posing significant challenges in wound management. NATROX® O₂ addresses these challenges by delivering oxygen directly to the wound site, promoting collagen synthesis, and mitigating the effects of radiation therapy.

Windy Cole, co-author of the study, underscores NATROX® O₂’s potential impact on fragile skin and impaired wound healing, highlighting observations of accelerated healing and pain alleviation. Emma Woodmansey, another co-author, emphasizes the importance of exploring innovative wound care solutions to address these challenges effectively.

The case series reports promising outcomes associated with NATROX® O₂, including reductions in wound size, enhancements in tissue granulation, and reductions in pain levels. These findings suggest potential improvements in treatment strategies for late radiation tissue injury patients, offering hope for enhanced patient outcomes.

The study’s publication in WOUNDS journal signifies a significant milestone in understanding the potential applications of NATROX® O₂ in wound management. As a company committed to evidence-based wound care, NATROX Wound Care continues to support and advocate for continued research into innovative therapies like NATROX® O₂ to improve treatment approaches and patient outcomes in the field of post-surgical wound care.

Read the full WOUNDS article here: https://bit.ly/RadiationWounds

Contact NATROX® Wound Care

NATROX® Wound Care